Trump “has a small personal financial interest” in Sanofi, the French drugmaker that makes Plaquenil
Many people have been wondering what's going on with the announcement by the Trump administration that Kodak has been contracted to produce pharmaceutical APIs here in the US
He spent much of his time touting the Its free cash flow — while improving from negative $110 million in 2017 — was $0 in 2019
This will enable Kodak to produce ingredients for drugs like hydroxychloroquine which Trump supported in treatment for COVID-19, as per the Wall Street Journal
We'll see if their stock stays up if it turns out they're only making hydroxychloroquine
Instead, the president appears alone in the White House briefing room to deliver a key announcement — on Tuesday, it was a $765 million deal with Kodak to produce pharmaceutical ingredients Kodak bought Sterling-Winthrop pharmaceuticals in 1988 for $5
Maintenance dose: 200 to 400 mg salt (155 to 310 mg base)/day orally divided in 1 or 2 doses
(Alex Wong/Getty Images) In a deal aimed at reducing U